Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Qi-min Yao"'
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
BackgroundTreating persistent, recurrent, or metastatic cervical cancer remains challenging. Although pembrolizumab, combined with chemotherapy and bevacizumab, offers a promising first-line option, its cost-effectiveness within the Chinese healthcar
Externí odkaz:
https://doaj.org/article/c6fe18137b1e4a0481645ec23180d52d
